Nos revues

Impact Factor 2020 : 11.000

Select stage:(Stage filter not available for Subtopic view)

Full list:

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation

Altered fractionation of thoracic radiation therapy for localised small cell lung cancer

Anti-angiogenic therapy for lung cancer

Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol

Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis

Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer

Chemotherapy and surgery versus surgery alone in non-small cell lung cancer

Chemotherapy for advanced non-small cell lung cancer in the elderly population

Chemotherapy for brain metastases from small cell lung cancer

Chemotherapy for non-small cell lung cancer

Chemotherapy versus best supportive care for extensive small cell lung cancer

Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Concurrent chemoradiotherapy in non-small cell lung cancer

Drugs for preventing lung cancer in healthy people

Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second-line treatment for non–small-cell lung cancer wild-type or unknown status for EGFR

Exercise training for advanced lung cancer

Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

Gabapentinoids for chronic post-thoracotomy pain after lung surgery in adults

Gefitinib for advanced non-small cell lung cancer

Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide versus platinum-etoposide alone for first-line treatment of extensive small cell lung cancer

Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) versus chemotherapy for second- or third-line treatment of metastatic non-small cell lung cancer

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol

Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent

Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol

Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality

Interventions for smoking cessation in people diagnosed with lung cancer

Limited resections versus lobectomy for stage I non-small cell lung cancer

Non-invasive interventions for improving well-being and quality of life in patients with lung cancer

Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients

Palliative endobronchial brachytherapy for non-small cell lung cancer

Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer

Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma

PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer

Postoperative radiotherapy for non-small cell lung cancer

Preoperative exercise training for people with non-small cell lung cancer

Prophylactic cranial irradiation for extensive-stage small cell lung cancer

Prophylactic cranial irradiation for patients with limited-stage small cell lung cancer

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer

Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma

Radical multimodality therapy for malignant pleural mesothelioma

Radiotherapy for malignant pleural mesothelioma

Screening for lung cancer

Second-line chemotherapy for non-small cell lung cancer

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non-small cell lung cancer: a systematic review and network meta-analysis

Surgery for limited-stage small-cell lung cancer

Surgery for local and locally advanced non-small cell lung cancer

Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer

Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer

Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer

Taxanes for advanced non-small cell lung cancer

Therapeutic vaccines for advanced non-small cell lung cancer

Third-line systemic chemotherapy for small cell lung cancer

Third-line systemic treatment for non-small cell lung cancer

Video-assisted thoracoscopic lobectomy versus open thoracotomy conventional lobectomy for stage I non-small cell lung cancer

By subtopic:

Diagnosis (1)

PET-CT (1)

PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer

Staging (0)

Prevention (all lung cancer) (2)

Occupational protection (0)

Environmental protection (0)

Chemoprevention (1)

Drugs for preventing lung cancer in healthy people

Tobacco avoidance, including passive smoking (covered by the Tobacco Addiction Group) (0)

Others (1)

Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients

Early detection (all lung cancer) (4)

Blood test (0)

Radiology (1)

Screening for lung cancer

Sputum Cytology (1)

Screening for lung cancer

Computerized Tomography (CT) (2)

Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality

Screening for lung cancer

Magnetic Resonance Imaging (MRI) (0)

Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol (protocol stage)

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Surgery (5)

Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)

Preoperative exercise training for people with non-small cell lung cancer

Limited resections versus lobectomy for stage I non-small cell lung cancer (protocol stage)

Surgery for local and locally advanced non-small cell lung cancer

Video-assisted thoracoscopic lobectomy versus open thoracotomy conventional lobectomy for stage I non-small cell lung cancer (protocol stage)

Chemotherapy (18)

Gefitinib for advanced non-small cell lung cancer

Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status (protocol stage)

Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol (protocol stage)

Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer

Chemotherapy for non-small cell lung cancer

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Chemotherapy for advanced non-small cell lung cancer in the elderly population

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) versus chemotherapy for second- or third-line treatment of metastatic non-small cell lung cancer (protocol stage)

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol (protocol stage)

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Second-line chemotherapy for non-small cell lung cancer

Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer

Taxanes for advanced non-small cell lung cancer (protocol stage)

Third-line systemic treatment for non-small cell lung cancer (protocol stage)

Radiotherapy (7)

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol (protocol stage)

Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)

Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer

Palliative endobronchial brachytherapy for non-small cell lung cancer

Postoperative radiotherapy for non-small cell lung cancer

Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer

Combined modality therapy (10)

Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation (protocol stage)

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol (protocol stage)

Concurrent chemoradiotherapy in non-small cell lung cancer

Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second-line treatment for non–small-cell lung cancer wild-type or unknown status for EGFR (protocol stage)

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol (protocol stage)

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer

Chemotherapy and surgery versus surgery alone in non-small cell lung cancer

Therapeutic vaccines for advanced non-small cell lung cancer (protocol stage)

Holistic/complementary/non-invasive therapies (2)

Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer

Preoperative exercise training for people with non-small cell lung cancer

SCLC (11)

Surgery (1)

Surgery for limited-stage small-cell lung cancer

Chemotherapy (5)

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer

Chemotherapy versus best supportive care for extensive small cell lung cancer

Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide versus platinum-etoposide alone for first-line treatment of extensive small cell lung cancer (protocol stage)

Chemotherapy for brain metastases from small cell lung cancer

Third-line systemic chemotherapy for small cell lung cancer (protocol stage)

Radiotherapy (4)

Altered fractionation of thoracic radiation therapy for localised small cell lung cancer (protocol stage)

Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer

Prophylactic cranial irradiation for extensive-stage small cell lung cancer (protocol stage)

Prophylactic cranial irradiation for patients with limited-stage small cell lung cancer (protocol stage)

Combined modality therapy (0)

Holistic/complementary/non-invasive therapies (0)

immunotherapy (1)

Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide versus platinum-etoposide alone for first-line treatment of extensive small cell lung cancer (protocol stage)

All lung cancer (7)

Surgery (2)

Gabapentinoids for chronic post-thoracotomy pain after lung surgery in adults (protocol stage)

Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer

Chemotherapy (1)

Anti-angiogenic therapy for lung cancer (protocol stage)

Radiotherapy (0)

Combined modality therapy (1)

Interventions for smoking cessation in people diagnosed with lung cancer

Holistic/complementary/non-invasive therapies (3)

Exercise training for advanced lung cancer

Non-invasive interventions for improving well-being and quality of life in patients with lung cancer

Interventions for smoking cessation in people diagnosed with lung cancer

Radical multimodality therapy for malignant pleural mesothelioma

Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma

Radiotherapy (3)

Radical multimodality therapy for malignant pleural mesothelioma

Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma (protocol stage)

Radiotherapy for malignant pleural mesothelioma

Language:

Cochrane
Lung Cancer

Nos revues

Full list:

By subtopic:

New and Updated (in the latest issue of the CLib):